Martin P Redmon

USPTO Granted Patents = 14 (Patent Applications = 5)

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 7)

Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 354(Granted Patents)

Location History:

Marlborough, MA (US) (2000)
Oxford, MA (US) (2003 - 2021)
Boston, MA (US) (2023 - 2024)

Company Filing History:

6 out of 69

Stealth Biotherapeutics Inc.

4. 1 out of 832,680

Other

patents

Years Active: 2000-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12252553 - Crystalline salt forms (2025-03-18),

2. 12018094 - Crystalline dipeptides useful in the synthesis of elamipretide (2024-06-25),

3. 11560404 - Crystalline dipeptides useful in the synthesis of elamipretide (2023-01-24),

4. 11555053 - Crystalline salt forms (2023-01-17),

5. 10975118 - Crystalline dipeptides useful in the synthesis of elamipretide (2021-04-13),

6. 10683326 - Crystalline salt forms (2020-06-16),

7. 9499540 - Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same (2016-11-22),

8. 8871933 - Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same (2014-10-28),

9. 8552192 - Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same (2013-10-08),

10. 7790765 - Hydroxy sulfonate of quinone compounds and their uses (2010-09-07),

11. 6627646 - Norastemizole polymorphs (2003-09-30),

12. 6161536 - Dosage form for aerosol administration (2000-12-19),

13. 6123956 - Methods for universally distributing therapeutic agents to the brain (2000-09-26),

14. 6040344 - Formoterol process (2000-03-21),

Title: The Innovative Contributions of Martin P Redmon

Introduction

Martin P Redmon is a notable inventor based in Oxford, MA, with a remarkable portfolio of 14 patents. His work primarily focuses on the development of crystalline forms of peptides, which have significant implications in the field of biotherapeutics.

Latest Patents

Among his latest patents, Redmon has disclosed various crystalline salt forms of D-Arg-Dmt-Lys-Phe-NH. Additionally, he has developed crystalline dipeptides that are useful in the synthesis of elamipretide, specifically highlighting crystalline forms of L-Lys(Boc)-Phe-NH and Boc-D-Arg-DMT. These innovations are crucial for advancing therapeutic applications.

Career Highlights

Throughout his career, Martin P Redmon has worked with prominent companies such as Stealth Biotherapeutics Inc. and Arqule, Inc. His contributions to these organizations have been instrumental in pushing the boundaries of biotherapeutic research and development.

Collaborations

Redmon has collaborated with esteemed colleagues, including Scott M Duncan and David P Reed. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Martin P Redmon's contributions to the field of biotherapeutics through his patents and collaborations underscore his significance as an inventor. His work continues to influence advancements in medical science and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.